Moderna
MRNA
#1332
Rank
ยฃ10.25 B
Marketcap
ยฃ26.53
Share price
-2.03%
Change (1 day)
-68.11%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total debt

Total debt on the balance sheet as of December 2024 : ยฃ0.57 Billion

According to Moderna 's latest financial reports the company's total debt is ยฃ0.57 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Moderna - Total debt on balance sheet (from 2017 to 2024)

Total debt by year

Year Total debt Change
2024-12-31ยฃ0.59 B-38.99%
2023-12-31ยฃ0.97 B-1.64%
2022-12-31ยฃ0.99 B46.17%
2021-12-31ยฃ0.67 B290.29%
2020-12-31ยฃ0.17 B72.25%
2019-12-31ยฃ0.10 B282.6%
2018-12-31ยฃ26.38 M127.3%
2017-12-31ยฃ11.6 M14.58%
2016-12-31ยฃ10.13 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
ยฃ0.36 M-99.94%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ28.70 B 4,868.01%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ14.36 M-97.51%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.00 B 73.50%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ24.17 B 4,084.47%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
ยฃ0.40 B-29.68%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ28.33 B 4,804.15%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA